 | Up a level |
Hammes, J., Hohberg, M., Taeger, P., Wild, M., Zlatopolskiy, B., Krapf, P., Neumaier, B., Schomaecker, K., Kobe, C., Schmidt, M., Dietlein, M. and Drzezga, A. (2018). Uptake In Non-affected Bone Tissue Does Not Differ Between [18f]-DCFPyL And [68Ga]-HBED-CC PSMA PET/CT. Eur. J. Nucl. Med. Mol. Imaging, 45. S. S535 - 1. NEW YORK: SPRINGER. ISSN 1619-7089
Hohberg, M., Dietlein, M., Kobe, C., Dietlein, F., Zlatopolskiy, B., Krapf, P., Wild, M., Taeger, P., Neumaier, B. and Drzezga, A. (2018). Biodistribution and radiation dosimetry of the novel F-18-labeled prostate-specific membrane antigen-ligand PSMA-7 for PET/CT in prostate cancer patients. Eur. J. Nucl. Med. Mol. Imaging, 45. S. S149 - 2. NEW YORK: SPRINGER. ISSN 1619-7089
Hohberg, M., Kobe, C., Taeger, P., Hammes, J., Schmidt, M., Dietlein, F., Wild, M., Heidenreich, A., Drzezga, A. and Dietlein, M. (2019). Combined Early and Late [Ga-68]PSMA-HBED-CC PET Scans Improve Lesion Detectability in Biochemical Recurrence of Prostate Cancer with Low PSA Levels. Mol. Imaging. Biol., 21 (3). S. 558 - 567. NEW YORK: SPRINGER. ISSN 1860-2002